MannKind Corp
MNKD
#6088
Rank
โ‚น109.51 B
Marketcap
โ‚น340.59
Share price
-0.28%
Change (1 day)
-27.85%
Change (1 year)

EPS for MannKind Corp (MNKD)

EPS in 2026 (TTM): -โ‚น6.50

According to MannKind Corp's latest financial reports the company's current EPS (TTM) is -โ‚น6.72. In 2025 the company made an earnings per share (EPS) of โ‚น1.92 a decrease over its 2024 EPS that were of โ‚น9.59.

EPS history for MannKind Corp from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น6.50-438.62%
2025โ‚น1.92-80%
2024โ‚น9.59
2022-โ‚น32.626.25%
2021-โ‚น30.7028%
2020-โ‚น23.99-7.41%
2019-โ‚น25.90
2017-โ‚น106.49-188.1%
2016โ‚น120.88-128.31%
2015-โ‚น426.9374.51%
2014-โ‚น244.65-20.31%
2013-โ‚น307.01-32.63%
2012-โ‚น455.72-28.03%
2011-โ‚น633.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น125.68-1,971.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
โ‚น412.10-6,236.29%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
โ‚น2,708-40,421.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น342.97-5,206.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
โ‚น280.14-4,271.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-โ‚น807.81 11,928.57%๐Ÿ‡บ๐Ÿ‡ธ USA